These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8392608)

  • 21. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections.
    Maciejewski S; Nguyen JH; Gómez-Herreros F; Cortés-Ledesma F; Caldecott KW; Semler BL
    mBio; 2015 Dec; 7(1):e01931-15. PubMed ID: 26715620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase.
    Haghighat A; Svitkin Y; Novoa I; Kuechler E; Skern T; Sonenberg N
    J Virol; 1996 Dec; 70(12):8444-50. PubMed ID: 8970966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects.
    Ventoso I; Carrasco L
    J Virol; 1995 Oct; 69(10):6280-8. PubMed ID: 7666528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores.
    Belov GA; Lidsky PV; Mikitas OV; Egger D; Lukyanov KA; Bienz K; Agol VI
    J Virol; 2004 Sep; 78(18):10166-77. PubMed ID: 15331749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification, properties, and mutagenesis of poliovirus 3C protease.
    Baum EZ; Bebernitz GA; Palant O; Mueller T; Plotch SJ
    Virology; 1991 Nov; 185(1):140-50. PubMed ID: 1656583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.
    Jewell JE; Ball LA; Rueckert R
    J Virol; 1990 Mar; 64(3):1388-93. PubMed ID: 2154618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of substrate recognition by poliovirus 2A proteinase.
    Hellen CU; Lee CK; Wimmer E
    J Virol; 1992 Jun; 66(6):3330-8. PubMed ID: 1316450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
    Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F.
    Wyckoff EE; Hershey JW; Ehrenfeld E
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9529-33. PubMed ID: 2175904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif.
    Sommergruber W; Ahorn H; Klump H; Seipelt J; Zoephel A; Fessl F; Krystek E; Blaas D; Kuechler E; Liebig HD
    Virology; 1994 Feb; 198(2):741-5. PubMed ID: 8291255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the poliovirus 3CD proteinase S1-specificity pocket affect substrate recognition and RNA binding.
    Blair WS; Nguyen JH; Parsley TB; Semler BL
    Virology; 1996 Apr; 218(1):1-13. PubMed ID: 8615011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foot-and-mouth disease virus Lb proteinase can stimulate rhinovirus and enterovirus IRES-driven translation and cleave several proteins of cellular and viral origin.
    Ziegler E; Borman AM; Kirchweger R; Skern T; Kean KM
    J Virol; 1995 Jun; 69(6):3465-74. PubMed ID: 7745693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human rhinovirus-14 protease 3C (3Cpro) binds specifically to the 5'-noncoding region of the viral RNA. Evidence that 3Cpro has different domains for the RNA binding and proteolytic activities.
    Leong LE; Walker PA; Porter AG
    J Biol Chem; 1993 Dec; 268(34):25735-9. PubMed ID: 8245010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity.
    Yu SF; Benton P; Bovee M; Sessions J; Lloyd RE
    J Virol; 1995 Jan; 69(1):247-52. PubMed ID: 7983716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct cleavage of elF4G by poliovirus 2A protease is inefficient in vitro.
    Bovee ML; Lamphear BJ; Rhoads RE; Lloyd RE
    Virology; 1998 Jun; 245(2):241-9. PubMed ID: 9636363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human rhinovirus 2A proteinase mutant and its second-site revertants.
    Luderer-Gmach M; Liebig HD; Sommergruber W; Voss T; Fessl F; Skern T; Kuechler E
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):213-8. PubMed ID: 8761474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease.
    Park N; Skern T; Gustin KE
    J Biol Chem; 2010 Sep; 285(37):28796-805. PubMed ID: 20622012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral proteinase requirements for the nucleocytoplasmic relocalization of cellular splicing factor SRp20 during picornavirus infections.
    Fitzgerald KD; Chase AJ; Cathcart AL; Tran GP; Semler BL
    J Virol; 2013 Mar; 87(5):2390-400. PubMed ID: 23255796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single amino acid change in protein synthesis initiation factor 4G renders cap-dependent translation resistant to picornaviral 2A proteases.
    Lamphear BJ; Rhoads RE
    Biochemistry; 1996 Dec; 35(49):15726-33. PubMed ID: 8961935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues.
    Neubauer D; Aumayr M; Gösler I; Skern T
    J Gen Virol; 2013 Jul; 94(Pt 7):1535-1546. PubMed ID: 23580429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.